Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
14.2%
operating margin TTM
-0.04%
revenue TTM
107.95 Million
revenue per share TTM
1.86$
valuation ratios | |
|---|---|
| pe ratio | 16.44 |
| peg ratio | 0.08 |
| price to book ratio | 2.39 |
| price to sales ratio | 2.41 |
| enterprise value multiple | 33.46 |
| price fair value | 2.39 |
profitability ratios | |
|---|---|
| gross profit margin | 77.47% |
| operating profit margin | -0.04% |
| pretax profit margin | 14.63% |
| net profit margin | 14.2% |
| return on assets | 12.44% |
| return on equity | 22.53% |
| return on capital employed | -0.04% |
liquidity ratios | |
|---|---|
| current ratio | 7.59 |
| quick ratio | 7.59 |
| cash ratio | 4.54 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 153.46 |
| days of payables outstanding | 18.59 |
| cash conversion cycle | 134.87 |
| receivables turnover | 2.38 |
| payables turnover | 19.63 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.04 |
| debt equity ratio | 0.05 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.05 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -4.36 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.23 |
| cash per share | 0.72 |
| operating cash flow per share | -0.23 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -4.36 |
| short term coverage ratios | -6.45 |
| capital expenditure coverage ratio | 0.00 |
Frequently Asked Questions
When was the last time Spero Therapeutics, Inc. (NASDAQ:SPRO) reported earnings?
Spero Therapeutics, Inc. (SPRO) published its most recent earnings results on 13-11-2025.
What is Spero Therapeutics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Spero Therapeutics, Inc. (NASDAQ:SPRO)'s trailing twelve months ROE is 22.53%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Spero Therapeutics, Inc. (SPRO) currently has a ROA of 12.44%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did SPRO's net profit margin stand at?
SPRO reported a profit margin of 14.2% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is SPRO's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 7.59 in the most recent quarter. The quick ratio stood at 7.59, with a Debt/Eq ratio of 0.05.